CTOs on the Move

Health Net

www.healthnet.com

 
Health Net is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net provides and administers health benefits to approximately 6.0 million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as “Part D”), Medicaid, dual eligible, U.S. Department of Defense, including TRICARE, and U.S. Department of Veterans Affairs programs. Health Net also offers behavioral health, substance abuse and employee assistance programs, and managed health care products related to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

SimpleHealth

SimpleHealth Founded in 2018 and based in New York City, SimpleHealth makes reproductive wellness simple! Operating in 32 states and growing, SimpleHealth is a nationally recognized telehealth provider of reproductive wellness, offering birth control, herpes and cold sore treatment, and over-the-counter supplements` SimpleHealth`s mission is to be the #1 reproductive wellness provider, giving access to those who otherwise wouldn`t be able to find reproductive care in a convenient and affordable way`

MedClean Technologies

MedClean Technologies is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PaxeraMed

PaxeraMed Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Morrow Institute, The

Morrow Institute, The is a Rancho Mirage, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.